Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4595 USD | +0.69% | -4.19% | -34.39% |
05-10 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-21 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
- Stock Market
- Equities
- NWBO Stock
- News Northwest Biotherapeutics, Inc.
- MarketScreener Editorial Features